Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury

Journal of Clinical Oncology

Volumn 18, Issue 3, 2000, Pages 463-467

  Sartori, Sergio ^a   Trevisani, Lucio ^a   Nielsen, Ingrid ^a   Tassinari, Davide ^a   Panzini, Ilaria ^a   Abbasciano, Vincenzo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; OMEPRAZOLE; PLACEBO; RANITIDINE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; COLON CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EPIGASTRIC PAIN; FEMALE; GASTRODUODENAL ULCER; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH MUCOSA INJURY;

EID: 0033951750     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.3.463     Document Type: Article

References (30)

1. Slavin RE, Dias MA, Saral R: Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: A clinical-pathological study of 33 patients. Cancer 42:1747-1759, 1978
2. Sartori S, Nielsen I, Maestri A, et al: Acute gastroduodenal mucosal injury after cisplatin plus etoposide chemotherapy. Oncology 48:356-361, 1991
3. Wang LS, Chi KH, Hu MH, et al: Management for patients with advanced T4 epidermoid carcinoma of the esophagus. J Surg Oncol 62:22-29, 1996
4. Kaur S, Cooper G, Fakult S, et al: Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation. Dig Dis Sci 41:598-603, 1996
5. Van Schil PE, Brutel de la Riviere A, Knaepen PJ, et al: Second primary lung cancer after bronchial resection: Treatment and results in eleven patients. J Thorac Cardiovasc Surg 104:1451-1455, 1992
6. Naunhein KS, Petruska P, Roy TS, et al: Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg 103:887-893, 1992
7. Liaw CC, Huang JS, Wang CM, et al: Spontaneous gastroduodenal perforation in patients with cancer receiving chemotherapy and steroids. Cancer 72:1382-1385, 1993
8. Mori K, Tominaga K, Yokoama K, et al: Efficacy of famotidine in patients with acute gastric mucosal injury after continuous infusion of cisplatin plus vindesine. J Cancer Res Clin Oncol 121:367-370, 1995
9. Sartori S, Trevisani L, Nielsen I, et al: Misoprostol and omeprazole in the prevention of chemotherapy induced acute gastroduodenal mucosal injury: A randomized, placebo-controlled pilot study. Cancer 78:1477-1482, 1996
10. Ogata Y, Shirouzu K, Akagi Y, et al: Hepatic arterial chemotherapy for liver metastases from colorectal cancer. Kurume Med J 43:41-47, 1996
11. Polloni A, Marchi S, Bellini M, et al: Use of antisecretory drugs for gastroprotection during antiblastic chemotherapy. Drugs Exp Clin Res 11:303-306, 1985
12. Mavligit GA, Faintuch J, Levin B, et al: Gastroduodenal mucosal injury during hepatic arterial infusion of chemotherapeutic agents: Lack of cytoprotection by prostaglandin E1 analogue. Gastroenterology 92:566-569, 1987
13. Jewell LD, Fields AL, Murray CJW: Erosive gastroduodenitis with marked atypia after hepatic arterial infusion chemotherapy. Am J Gastroenterol 80:421-424, 1985
14. Oken MM, Creech RH, Tormey DC: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
15. Lanza FL, Graham DY, Davis RE, et al: Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury: Effect of scoring method. Dig Dis Sci 35:1494-1499, 1990
16. Sartori S, Nielsen I, Trevisani L, et al: Barrett esophagus after antineoplastic chemotherapy. Endoscopy 22:152, 1990 (letter)
17. Sartori S, Trevisani L, Nielsen I, et al: Barrett's esophagus after continuous 5-fluorouracil infusion: A case report. Gastrointest Cancer 2:163-165, 1997
18. Lubitz L, Ekert H: Reversible changes in duodenal mucosa associated with intensive chemotherapy followed by autologous marrow rescue. Lancet 2:532-533, 1979
19. Brinker H: Treatment of therapy-resistant acute myeloid leukemia with 7 and 8 cytostatics. Scand J Haematol 14:35-41, 1975
20. Suda K, Seki T, Kano Y, et al: Continuous 5-fluorouracil infusion causing acute gastric mucosal lesions. Endoscopy 25:426-427, 1993
21. Lewis JH: Gastrointestinal toxicity due to medicinal agents. Am J Gastroenterol 81:819-834, 1986
22. Mitchell EP: Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol 5:566-579, 1992
23. Lewkow L, Hooker J, Raab M. et al: Phase I-II study of dose-intensive mitoxantrone and cyclophosphamide with autologous bone-marrow transplantation in metastatic breast cancer. Proc Am Soc Clin Oncol 9:98 1990 (abstr 145)
24. Sheperd FA, Laskey J, Evans WK, et al: Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer. J Clin Oncol 10:21-27, 1992
25. Duenas Gonzalez A, Sobrevilla Calvo P, Frias Mendivil M, et al: Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: A randomized double-blind study. Bone Marrow Transplant 17:809-812, 1996
26. Kakinuma S, Ohwada S: Gastric mucosal blood flow and gastric secretion following intravenous administration of 5-fluorouracil in anesthetized rats. Cancer Chemother Pharmacol 39:357-360, 1997
27. Lanzon-Miller S, Pounder RE, Hamilton MR: Twenty-four intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1:239-251, 1987
28. Olbe L, Cederberg C, Lind T, et al: Effect of omeprazole on gastric acid secretion and plasma gastrin. J Gastroenterol Hepatol 4:19-25, 1989 (suppl 2)
29. Chiverton SG, Hunt RH: Relationship between inhibition of acid secretion and healing of peptic ulcers. Scand J Gastroenterol 166:43-47, 1989 (suppl 1)
30. Savarino V, Mela GS, Zentilin P, et al: Duration of acid suppression in H2-antagonist nonresponders. Digestion 51:185-192, 1992